Where The Moonshot Meets The Road: Could Biden's Plan Boost Cures Bill?
Maybe, but Sen. Alexander lists 21st Century Cures-like legislation below education issues on his 2016 priority list.
You may also be interested in...
Drug companies and NIH embrace Vice President’s call for moonshot to cure cancer; Amgen and Celgene join separate coalition to test 60 molecules in combination Phase II studies.
Congress should give FDA more flexibility to administer orphan designations, such as the ability to revoke designations later if the disease prevalence grows beyond the rare disease threshold.
ACIP defers vote on who should be inoculated first until it has data on a specific product, but vaccine acceptance among different groups could be weighed as factor in setting distribution priorities, committee members suggest.